Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implant Market Research Report Information by Diagnosis & Treatment {(Diagnosis [Microbiological Culture Test, Polymerase Chain Reaction, and Imaging Studies {Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and Ultrasonography}, Treatment(Antibiotics, Antimicrobial Therapy, and Surgery)}, by End User (Hospitals, Ambulatory Surgery Centers, and Others), by Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2032

Global Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implant Market Overview

Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implant Market size was valued at USD 2.31 billion in 2022. The staphylococcus aureus infection diagnosis and treatment for orthopedic implant market industry is projected to grow from USD 2.40 Billion in 2023 to USD 3.87 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.89% during the forecast period (2023 - 2032). The growing number of orthopedic surgeries associated with implants and increasing incidence of fractures are driving market growth.

Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implant Market Trends

• 
  

  The growing number of orthopedic surgeries associated with implants boosts market growth.

  
  

The increasing number of orthopedic surgeries is booming the demand for staphylococcus aureus infection diagnosis and treatment for orthopedic implant. For instance, in July 2023, Cleveland Clinic (US) reported that approximately 800,000 knee replacements are performed each year in the US. Moreover, as per the American Association of Hip and Knee Surgeons, prosthetic joint infection (PJI) stands out as a severe issue following total hip arthroplasty (THA), especially when other health conditions are present, which heightens the risk. The percentage of infections linked to staphylococcus aureus rose from 26.3% during 2008–2009 to 40% between 2020 and 2021.

Furthermore, according to the Organization for Economic Co-operation and Development (OECD), between 2009 and 2019, the number of hip replacements went up by 22%, and knee replacements rose by 35% on average. Hence, the increasing number of implant surgeries may lead to an increase in staphylococcus aureus, fuelling global staphylococcus aureus infection diagnosis and treatment for the orthopedic implant market.

Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implant Market Segment Insights

Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implant Diagnosis & Treatment Insights

The Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implant Market segmentation, based on diagnosis & treatment, includes Diagnosis further segmented into microbiological culture test, polymerase chain reaction, imaging studies. Imaging studies bifurcated into computed tomography (CT), magnetic resonance imaging (MRI), ultrasonography. Treatment segmented into antibiotics, antimicrobial therapy, and surgery. The treatment segment held the majority share in 2022 in the Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implant Market revenue. This is attributed to the prompt administration of antibodies ca prevent the spread of infection from the implant site to surrounding tissue and bloodstream, reducing the risk of serious complications such as septicemia and osteomyelitis and growing use of antimicrobial therapy. Additionally, surgery provides direct access to the site of illness, making it easier to identify and sample any tissue, fluids, or biofilms linked to the infection.

Staphylococcus Aureus Infection Diagnosis And Treatment For Orthopedic Implant Market Size, By Diagnosis & Treatment, 2022 & 2032 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implant End User Insights

The Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implant Market segmentation is based on end user that includes hospitals, ambulatory surgical centers, and others. The Hospitals segment has dominated the market in 2022 and the ambulatory surgery centers segment is projected to be the fastest-growing segment during the forecast period, 2023-2032. This is due to the specialized expertise, comprehensive treatment options, and diagnostics resources.

Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implant Regional Insights

By Region, the study segments the market into US, Europe, China, Middle East & North Africa, and the Rest of the World. The North America staphylococcus aureus infection diagnosis and treatment for orthopedic implant market accounted for the largest market share in 2022. This is due to the rise in the prevalence of staphylococcus aureus infection in orthopedic implant, excellent healthcare infrastructure and rise in number of orthopedic surgeries in the North America region. Companies such as Xellia Pharmaceuticals (Germany), Wellona Pharma (India), Schwitz Biotech (India), and Merck KGaA (Germany) are actively working on improving staphylococcus aureus infection diagnosis and treatment for orthopedic implant and fulfilling the demands of customers.

Further, the major countries studied are the US, Germany, France, UK, Italy, Spain, and China and Others.

Figure 3: Staphylococcus Aureus Infection Diagnosis And Treatment For Orthopedic Implant Market Size, By Region 2022 & 2032 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

The Europe staphylococcus aureus infection diagnosis and treatment for orthopedic implant market accounts for the second-largest market share due to growing aging population, favorable reimbursement policies, across the country. further, Germany staphylococcus aureus infection diagnosis and treatment for orthopedic implant market was attributed to hold the largest market share, and the UK staphylococcus aureus infection diagnosis and treatment for orthopedic implant market is expected to fastest-growing market in the European region.

The Asia-Pacific staphylococcus aureus infection diagnosis and treatment for orthopedic implant market is expected to grow at a significant share from 2023 to 2032. This is due to the rapid population growth, government initiatives and investments, and collaboration among healthcare stakeholders in the region. Moreover, China staphylococcus aureus infection diagnosis and treatment for orthopedic implant market is expected to hold the largest market share, and India staphylococcus aureus infection diagnosis and treatment for orthopedic implant market is expected fastest-growing market in the Asia-Pacific region.

Furthermore, growing healthcare infrastructure, increasing awareness and patient education boosts the market growth for staphylococcus aureus infection diagnosis and treatment for orthopedic implant market.

The Rest of the World is segmented into the Middle East, Africa, and Latin America. The staphylococcus aureus infection diagnosis and treatment for orthopedic implant market in the above-mentioned regions is likely to witness growth due to ongoing research and development efforts aimed at developing novel diagnostic technologies, therapeutics, and preventive strategies. Moreover, limited availability and affordability is affecting the market's growth to some extent in these regions.

Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implant Key Market Players & Competitive Insights

The Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implant Market is characterized by the presence of many global, regional, and local vendors. Developments in the healthcare industry and growing research and development make the staphylococcus aureus infection diagnosis and treatment for orthopedic implant market lucrative. To expand their reach and optimize their operational costs, the major players focus on obtaining regulatory authorizations from government agencies for their products and emphasize acquisitions and product launches to gain a substantial market share. The market comprises tier-1, tier-2, and local players. The tier-1 and tier-2 players have reach across the globe with diverse product portfolios. Companies such as Xellia Pharmaceuticals (Germany), Wellona Pharma (India), Schwitz Biotech (India), and Merck KGaA (Germany) dominate the Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implant Market due to product differentiation, financial stability, strategic developments, and diversified regional presence. The players are focused on investing in research and development. Furthermore, they adopt strategic growth initiatives, such as expansion, product launches, joint ventures, and partnerships, to strengthen their market position and capture a large customer base.

One of the primary business strategies adopted by manufacturers in the global staphylococcus aureus infection diagnosis and treatment for orthopedic implant industry to benefit clients and expand the staphylococcus aureus infection diagnosis and treatment for orthopedic implant market sector is to manufacture locally to reduce operating costs.

Xellia Pharmaceuticals produces pharmaceutical products. The Company offers anti-infective products and treatments, as well as contract manufacturing, stability testing, and packaging services for dry powder filled vials. The company's anti-infection treatments are genetically prepared to combat serious bacterial and antibiotic-resistant infections as well as certain fungal diseases, thereby helping clients with improved formulations, drug-device combinations, and in the long term, new anti-infection compounds. Xellia serves customers worldwide. It has operations across 45 countries in all regions, namely the Americas, Europe, Asia-Pacific, and the Middle East & Africa. It is wholly owned by Novo Holdings A/S since 2013 and headquartered in Copenhagen, Denmark

Also, Siemens healthineers AG (Germany) is a technology-driven company that focuses on developing innovative products. The company has a strong distribution network and offers its products to more than five million patients worldwide. It has a strong network and presence in over 200 countries. Siemens operates through segments, namely, imaging, diagnostics, advanced therapies, and services. It operates through multiple production and manufacturing facilities, office buildings, warehouses, R&D facilities, and sales facilities in Beijing, Boston, London, Munich, Paris, Palo Alto, Stockholm, and Tel Aviv.

Key Companies in the Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implant Market include

• Xellia Pharmaceuticals (Germany)


• Wellona Pharma (India)


• Schwitz Biotech (India)


• Merck KGaA (Germany)


• Thermo Fisher Scientific Inc (US)


• BioMérieux SA (France)


• Siemens healthineers AG (Germany)


• Beckman Coulter Inc (US)


• Hoffmann-La Roche Ltd (Switzerland)


• Pfizer Inc (US)

Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implant Industry Developments

November 2023: Siemens Healthineers AG announced the approval from the US Food and Drug Administration (FDA) for its positron emission tomography/computed tomography (PET/CT) scanner, Biograph Vision.X.

Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implant Market Segmentation

Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implant Diagnosis & Treatment Outlook

• Diagnosis
  
  
  
  • Microbiological Culture Test
  
  
  • Polymerase Chain Reaction
  
  
  • Imaging Studies
  
  
  • Computed Tomography (CT)
  
  
  • Magnetic Resonance Imaging (MRI)
  
  
  • Ultrasonography
  
  
  
  


• Treatment
  
  
  
  • Antibiotics
  
  
  • Antimicrobial Therapy
  
  
  • Surgery
  
  
  
  

Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implant Product Outlook

• Hospitals


• Ambulatory Surgery Centers


• Others

Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implant Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America